Guide to Selecting the Right Serialisation partner
For most pharmaceutical companies, it is becoming increasingly complex to stay up-to-date with compliant with the evolving requirements and guidance surrounding anti-counterfeiting regulations. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 5, 2017 Category: Pharmaceuticals Source Type: news

Takeda and Noile-Immune to jointly develop new CAR-T immunotherapies for cancer
Takeda Pharmaceutical has entered a collaboration with Noile-Immune Biotech to develop next-generation chimeric antigen receptor T-cell (CAR-T) therapy for solid tumours. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 4, 2017 Category: Pharmaceuticals Source Type: news

Janssen and Mundipharma sign distribution deal for type 2 diabetes treatments
Janssen Pharmaceutica has entered an exclusive distribution agreement with Mundipharma Medical Company for Invokana (canagliflozin) and Vokanamet (a fixed-dose combination therapy of canagliflozin and metformin) to treat patients with type 2 diabetes … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 4, 2017 Category: Pharmaceuticals Source Type: news

Therapure Biopharma to divest CDMO business for $290m
A joint venture (JV) between 3SBio and CPE Funds has entered an asset purchase agreement to purchase Canadian biologics manufacturer Therapure Biopharma ’s contract development and manufacturing (CDMO) business, Therapure Biomanufacturing, for $290m. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 4, 2017 Category: Pharmaceuticals Source Type: news

Origin to Attend GLOBAL CPhI Event in Messe, Frankfurt
Origin has announced it will be attending the GLOBAL CPhI event in Frankfurt, Germany (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 4, 2017 Category: Pharmaceuticals Source Type: news

Is Amazon gearing up to take on the US pharmacy market?
Reports that Amazon is considering breaking into the US pharmacy industry have sent ripples up and down the drug supply chain. Is there enough evidence to suggest that the retail and tech giant is truly serious about making such a move, and what coul … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 4, 2017 Category: Pharmaceuticals Source Type: news

LabCorp completes acquisition of Chiltern for $1.2bn
US-based global life sciences company LabCorp has completed the acquisition of Chiltern, a specialist contract research organisation (CRO), for approximately $1.2bn. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 3, 2017 Category: Pharmaceuticals Source Type: news

Pfizer ’s Mylotarg receives FDA approval for acute myeloid leukaemia treatment
The US Food and Drug Administration (FDA) has granted approval to Pfizer ’s antibody-drug conjugate (ADC) Mylotarg (gemtuzumab ozogamicin) for the treatment of patients with acute myeloid leukaemia (AML). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 3, 2017 Category: Pharmaceuticals Source Type: news

Sunovion submits NDA for dasotraline to US FDA to treat ADHD patients
Sunovion Pharmaceuticals has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for dasotraline to treat patients with attention deficit hyperactivity disorder (ADHD). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 3, 2017 Category: Pharmaceuticals Source Type: news

Telstar Consolidates Engineering and Construction Services
Telstar has completed a total of 35 high-complex projects for international pharmaceutical and biotechnology industries within the first half of 2017. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 1, 2017 Category: Pharmaceuticals Source Type: news

Fun-trition with Gummies
Gummies are an innovative, attractive alternative of delivering vitamins, minerals, and supplements (VMS), while maintaining the effectiveness of the traditional pill form. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 1, 2017 Category: Pharmaceuticals Source Type: news

WMFTG Quantum Peristaltic Pump with ReNu SU Technology
Watson-Marlow Fluid Technology Group (WMFTG) unveiled its innovative Quantum peristaltic pump with a patented ReNu single-use (SU) technology cartridge. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 1, 2017 Category: Pharmaceuticals Source Type: news

Atlant Clinical Completes an International, Multicenter, Double-Blind, Placebo-Controlled Clinical Trial in Patients with Prostate Cancer
Atlant Clinical has successfully completed an international, multicenter, double-blind, placebo-controlled, Phase IIIa study in patients with prostate cancer. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 1, 2017 Category: Pharmaceuticals Source Type: news

Amgen ’s Mimpara for secondary HPT children with ESRD receives marketing approval in EU
US-based biopharmaceutical company Amgen has been granted marketing authorisation by the European Commission (EC) for Mimpara (cinacalcet) to treat secondary hyperparathyroidism (HPT) in children with end ‑stage renal disease (ESRD). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 31, 2017 Category: Pharmaceuticals Source Type: news

Deals this week: Shenzhen Neptunus Bioengineering, Denis Chem Lab, Humanwell Healthcare
Shenzhen Neptunus Bioengineering plans to raise CNY1bn ($150.69m) through the private placement of debt financing instruments. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 31, 2017 Category: Pharmaceuticals Source Type: news